Psychedelic Bulletin #142: Terran’s IP Portfolio; AMA Advocates Against Non-Medical Psychedelics; Couple Receives First Psilocybin Services in Oregon; Mass. Ballot Measure Ramps Up; NIDA and NIMH Directors Opine

This Week: and lots more… Last spring, Terran Biosciences boasted that it had a portfolio of more than 150 patents. Since then, most of these patent applications have published.The company has largely operated in stealth, but analysis of the thousands of pages of patent applications provides some hints at their strategy. In our latest deep dive we consider what Terran’s end game might look like…

Source